Charles E. Prussak
12Patents
7h-index
11Co-inventors
63Inventor score
Filing activity: Jul 16, 1993 → Mar 16, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5447859A | Method for the purification or removal of retroviruses using sulfated cellulose | Chemistry; Metallurgy | 40 | Expired |
| US7495090B2 | Nucleic acids encoding chimeric CD154 polypeptides | Human Necessities | 30 | Expired |
| US7928213B2 | Nucleic acids encoding chimeric CD154 polypeptides | Human Necessities | 27 | Active |
| US5739018A | Packaging cell lines for pseudotyped retroviral vectors | Chemistry; Metallurgy | 23 | Expired |
| US5792643A | Methods for preserving recombinant retroviruses | Chemistry; Metallurgy | 14 | Expired |
| US7786282B2 | Nucleic acid molecules encoding TNF-α ligand polypeptides having a CD154 domain | Chemistry; Metallurgy | 13 | Expired |
| US9758591B2 | Antibodies and vaccines for use in treating ROR1 cancers and inhibiting metastasis | Chemistry; Metallurgy | 12 | Active |
| US10344096B2 | Antibodies and vaccines for use in treating ROR1 cancers and inhibiting metastasis | Chemistry; Metallurgy | 4 | Active |
| US11312787B2 | Antibodies and vaccines for use in treating ROR1 cancers and inhibiting metastasis | Chemistry; Metallurgy | 2 | Active |
| US8138310B2 | Chimeric CD154 polypeptides | Human Necessities | 2 | Active |
| US7964712B2 | Chimeric nucleic acids encoding polypeptides comprising TNF alpha, CD70 and FAS ligand domains | Chemistry; Metallurgy | 1 | Active |
| US12162950B2 | Antibodies and vaccines for use in treating ROR1 cancers and inhibiting metastasis | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.